GASTROESOPHAGEAL JUNCTION CARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION CARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New algorithm aims to keep chemo on schedule for cancer patients
Disease control Recruiting nowThis study tests a tool called PAGODA that helps doctors adjust chemotherapy doses ahead of time to avoid unplanned treatment delays. About 420 people with cancers of the digestive system (like colon, stomach, or esophageal cancer) will take part. The goal is to see if using this…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 00:41 UTC
-
New drug combo aims to fight tough stomach and esophageal cancers
Disease control Recruiting nowThis study tests whether adding the experimental drug givastomig to standard immunotherapy and chemotherapy helps people with advanced stomach or esophageal cancer live longer without their cancer growing. About 180 adults whose tumors have certain proteins (CLDN18.2 and PD-L1) w…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE2 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 17, 2026 00:41 UTC
-
Could a $10 antifungal boost cancer cure rates?
Disease control Recruiting nowThis study tests whether adding itraconazole, a widely used antifungal medication, to standard chemotherapy and radiation can help eliminate more esophageal cancer before surgery. About 78 adults with resectable esophageal or gastroesophageal junction cancer will take itraconazol…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for advanced cancer: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study tests an experimental drug called TJ033721 (givastomig) in people with advanced or metastatic solid tumors, including stomach, pancreatic, and bile duct cancers. The main goals are to check the drug's safety, find the best dose, and see how the body process…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE1 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Home cancer care trial aims to cut travel burden for florida patients
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for 27 adults with various cancers in the Florida Panhandle. The goal is to see if patients prefer home care and if it is safe. Participants will receive their usual cancer drugs either at home or in the clini…
Matched conditions: GASTROESOPHAGEAL JUNCTION CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC